InsidersTradesSigma
Follow the Baijin Life Science Holdings Ltd. share price and the full insider trade history of the company, a listed equity based in Hong Kong. Shares trade on the HK market, under the authority of HKEX. Operating in the Retail sector, Baijin Life Science Holdings Ltd. has logged 9 insider filings. Market capitalisation: €932.3m. The latest transaction was reported on 29 April 2026 (Purchase). Among the most active insiders: CHENG Chi Kin. All data is openly available.
9
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
n/a
Sell Volume
3Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,469 of 29,064 companies
16.5
score / 100
Value25
Quality8
FCF yld-2.9%
Earn yld-4.8%
EV/EBITDA·
ROE-25%
Gross mgn7.5%
Net mgn-42%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 April 2026
Declarations9 total
1,000,000 sharesShareXHKGHKEX:DA20260428E00528
932,000 sharesShareXHKGHKEX:DA20260428E00519
2,000,000 sharesShareXHKGHKEX:DA20260428E00340
2,933,765 sharesShareXHKGHKEX:DA20260429E00164
9,322,540 sharesShareXHKGHKEX:DA20260428E00086
932,000 sharesShareXHKGHKEX:DA20260428E00295
9 of 9 declarations
关于 Baijin Life Science Holdings Ltd.
百劲生物科技控股有限公司是一家专注于分销生命科学相关产品的公司。该公司在香港证券交易所上市。